Literature DB >> 6951176

Molecular basis of reovirus neurovirulence: role of the M2 gene in avirulence.

D B Hrdy, D H Rubin, B N Fields.   

Abstract

A number of field isolates of reovirus 3 were examined to determine their relative neurovirulence after intracerebral inoculation. One isolate was found that had decreased neurovirulence. This "avirulent" strain showed the typical type 3 neural tropism but grew significantly less well in brain tissue than T3 (Dearing) and the other type 3 reoviruses. The avirulent virus was not temperature-sensitive, and its yield in mouse L cells in vitro was similar to that of the laboratory strains. To determine the reason that this clone was avirulent, we isolated a series of reassortant progeny clones from crosses between the avirulent strain and T1 (Lang) and T3 (Dearing). Using these reassortants, we showed that avirulence was a property of the M 2 gene segment. The M2 segment was also responsible for conferring greater sensitivity to chymotryptic digestion on the avirulent strain, compared to more virulent strains. Prior studies have determined that the localization of virus in different cell types in the brain (tropism) is a property of the viral hemagglutinin, the product of the S1 RNA genome segment. Our studies thus indicate that the basis for relative neurovirulence does not reside in the viral hemagglutinin and clearly illustrate the multigenic nature of neurovirulence.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6951176      PMCID: PMC345950          DOI: 10.1073/pnas.79.4.1298

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  18 in total

1.  Protease activation mutants of sendai virus. Activation of biological properties by specific proteases.

Authors:  A Scheid; P W Choppin
Journal:  Virology       Date:  1976-01       Impact factor: 3.616

2.  Genome RNAs and polypeptides of reovirus serotypes 1, 2, and 3.

Authors:  R F Ramig; R K Cross; B N Fields
Journal:  J Virol       Date:  1977-06       Impact factor: 5.103

3.  Molecular basis of reovirus virulence: role of the S1 gene.

Authors:  H L Weiner; D Drayna; D R Averill; B N Fields
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

Review 4.  Genetic manipulation of reovirus--a model for modification of disease.

Authors:  B N Fields
Journal:  N Engl J Med       Date:  1972-11-16       Impact factor: 91.245

5.  Studies on the effect of chymotrypsin on reovirions.

Authors:  W K Joklik
Journal:  Virology       Date:  1972-09       Impact factor: 3.616

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  The nature of the polypeptide encoded by each of the 10 double-stranded RNA segments of reovirus type 3.

Authors:  M A McCrae; W K Joklik
Journal:  Virology       Date:  1978-09       Impact factor: 3.616

8.  Genetics of reovirus: identification of the ds RNA segments encoding the polypeptides of the mu and sigma size classes.

Authors:  T A Mustoe; R F Ramig; A H Sharpe; B N Fields
Journal:  Virology       Date:  1978-09       Impact factor: 3.616

9.  A genetic map of reovirus. II. Assignment of the double-stranded RNA-negative mutant groups C, D, and E to genome segments.

Authors:  R F Ramig; T A Mustoe; A H Sharpe; B N Fields
Journal:  Virology       Date:  1978-04       Impact factor: 3.616

10.  A genetic map of reovirus. 1. Correlation of genome RNAs between serotypes 1, 2, and 3.

Authors:  A H Sharpe; R F Ramig; T A Mustoe; B N Fields
Journal:  Virology       Date:  1978-01       Impact factor: 3.616

View more
  33 in total

1.  Thermostability of reovirus disassembly intermediates (ISVPs) correlates with genetic, biochemical, and thermodynamic properties of major surface protein mu1.

Authors:  Jason K Middleton; Tonya F Severson; Kartik Chandran; Anne Lynn Gillian; John Yin; Max L Nibert
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

2.  Identification of the viral genes responsible for growth of strains of reovirus in cultured mouse heart cells.

Authors:  Y Matoba; B Sherry; B N Fields; T W Smith
Journal:  J Clin Invest       Date:  1991-05       Impact factor: 14.808

3.  Sequence diversity in S1 genes and S1 translation products of 11 serotype 3 reovirus strains.

Authors:  T S Dermody; M L Nibert; R Bassel-Duby; B N Fields
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

4.  Reovirus infection and tissue injury in the mouse central nervous system are associated with apoptosis.

Authors:  S M Oberhaus; R L Smith; G H Clayton; T S Dermody; K L Tyler
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

5.  The reovirus M1 gene, encoding a viral core protein, is associated with the myocarditic phenotype of a reovirus variant.

Authors:  B Sherry; B N Fields
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

6.  Growth and survival of reovirus in intestinal tissue: role of the L2 and S1 genes.

Authors:  D K Bodkin; B N Fields
Journal:  J Virol       Date:  1989-03       Impact factor: 5.103

7.  Antibody protects against lethal infection with the neurally spreading reovirus type 3 (Dearing).

Authors:  H W Virgin; R Bassel-Duby; B N Fields; K L Tyler
Journal:  J Virol       Date:  1988-12       Impact factor: 5.103

8.  Novel strategy for treatment of viral central nervous system infection by using a cell-permeating inhibitor of c-Jun N-terminal kinase.

Authors:  J David Beckham; Robin J Goody; Penny Clarke; Christophe Bonny; Kenneth L Tyler
Journal:  J Virol       Date:  2007-05-02       Impact factor: 5.103

9.  Penetration of the nervous systems of suckling mice by mammalian reoviruses.

Authors:  A Flamand; J P Gagner; L A Morrison; B N Fields
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

10.  Reovirus apoptosis and virulence are regulated by host cell membrane penetration efficiency.

Authors:  Pranav Danthi; Takeshi Kobayashi; Geoffrey H Holm; Mark W Hansberger; Ty W Abel; Terence S Dermody
Journal:  J Virol       Date:  2007-10-24       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.